LMO2 and chronic myelogenous leukemia, BCR-ABL1 positive: The BCR-ABLp190, LMO2, and BCR-ABLp210 oncogenes play a role in human B-lymphocyte, acute T-lymphoblastic, and chronic myeloid leukaemia, respectively.